Perez-Stable, C.; de las Pozas, A.; Wangpaichitr, M.; Sha, W.; Wang, H.; Cai, R.; Schally, A.V.
Growth Hormone-Releasing Hormone (GHRH) Antagonist Peptides Combined with PI3K Isoform Inhibitors Enhance Cell Death in Prostate Cancer. Cancers 2025, 17, 1643.
https://doi.org/10.3390/cancers17101643
AMA Style
Perez-Stable C, de las Pozas A, Wangpaichitr M, Sha W, Wang H, Cai R, Schally AV.
Growth Hormone-Releasing Hormone (GHRH) Antagonist Peptides Combined with PI3K Isoform Inhibitors Enhance Cell Death in Prostate Cancer. Cancers. 2025; 17(10):1643.
https://doi.org/10.3390/cancers17101643
Chicago/Turabian Style
Perez-Stable, Carlos, Alicia de las Pozas, Medhi Wangpaichitr, Wei Sha, Haibo Wang, Renzhi Cai, and Andrew V. Schally.
2025. "Growth Hormone-Releasing Hormone (GHRH) Antagonist Peptides Combined with PI3K Isoform Inhibitors Enhance Cell Death in Prostate Cancer" Cancers 17, no. 10: 1643.
https://doi.org/10.3390/cancers17101643
APA Style
Perez-Stable, C., de las Pozas, A., Wangpaichitr, M., Sha, W., Wang, H., Cai, R., & Schally, A. V.
(2025). Growth Hormone-Releasing Hormone (GHRH) Antagonist Peptides Combined with PI3K Isoform Inhibitors Enhance Cell Death in Prostate Cancer. Cancers, 17(10), 1643.
https://doi.org/10.3390/cancers17101643